Back to search
FDAFDA · Food and drugs·Recall number D-0336-2015

Gabapentin Capsules, USP, 400 mg, Rx Only, a) 100 capsules per bottle, NDC 14550-513-02, b) 500 Capsules per bottle, NDC 45963-557-50, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA.

Published January 14, 2015 · Recall initiated: December 15, 2014

Summary

FDA records drug Class II recall D-0336-2015, published January 14, 2015 and initiated December 15, 2014. Recalling firm: Actavis Elizabeth LLC; Status: Terminated; Reported quantity: 10,857 Bottles; Lot: Lot #s: a) G01889A2 Exp 06/2015, b) G01942A1 Exp 08/2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

What to do

Voluntary: Firm initiated · Letter

Get an email if GABAPENTIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
GABAPENTIN
Manufacturer
Actavis Elizabeth LLC
Distributor
Puerto Rico
UPC
0345963555113
Lot
Lot #s: a) G01889A2 Exp 06/2015, b) G01942A1 Exp 08/2015
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Gabapentin Capsules, USP, 400 mg, Rx Only, a) 100 capsules per bottle, NDC 14550-513-02, b) 500 Capsules per bottle, NDC 45963-557-50, Manufactured by: Actavis Pharma Manufacturing Pvt. Ltd., Plot No 101, 102, 107, & 108, SIDCO Pharmaceutical Complex, Alathurt, Kanchipuram Dist-603 110, Tamlinadu, India, Distributed by: Actavis Elizabeth LLC, 700 Elmora Ave, Elizabeth, NJ 07207 USA. recalled?

Yes. FDA published recall D-0336-2015 on January 14, 2015. Reported hazard: Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: GABAPENTIN. UPC: 0345963555113.